Rank | Gene Set | Z-score |
---|---|---|
1 | low-density lipoprotein particle clearance (GO:0034383) | 8.59141158 |
2 | epithelial cell differentiation involved in kidney development (GO:0035850) | 8.08566808 |
3 | triglyceride catabolic process (GO:0019433) | 7.76376272 |
4 | acylglycerol catabolic process (GO:0046464) | 7.10757315 |
5 | neutral lipid catabolic process (GO:0046461) | 7.10757315 |
6 | positive regulation of p38MAPK cascade (GO:1900745) | 6.58750090 |
7 | transcytosis (GO:0045056) | 6.32259666 |
8 | regulation of sequestering of triglyceride (GO:0010889) | 6.12369259 |
9 | regulation of axon guidance (GO:1902667) | 5.42587121 |
10 | endothelial cell chemotaxis (GO:0035767) | 5.39256694 |
11 | surfactant homeostasis (GO:0043129) | 5.31173159 |
12 | diacylglycerol metabolic process (GO:0046339) | 5.25371175 |
13 | NADH metabolic process (GO:0006734) | 5.19105932 |
14 | glycerolipid catabolic process (GO:0046503) | 5.18586405 |
15 | regulation of p38MAPK cascade (GO:1900744) | 5.02508482 |
16 | lymphangiogenesis (GO:0001946) | 4.91327165 |
17 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.86365036 |
18 | coronary vasculature morphogenesis (GO:0060977) | 4.75219804 |
19 | cell adhesion mediated by integrin (GO:0033627) | 4.65546329 |
20 | negative regulation of axon guidance (GO:1902668) | 4.65214386 |
21 | activation of Rac GTPase activity (GO:0032863) | 4.58244690 |
22 | regulation of endothelial cell chemotaxis (GO:2001026) | 4.57937766 |
23 | positive regulation of cell adhesion mediated by integrin (GO:0033630) | 4.55499198 |
24 | renal filtration (GO:0097205) | 4.53669234 |
25 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.51145481 |
26 | angiotensin maturation (GO:0002003) | 4.50460706 |
27 | venous blood vessel morphogenesis (GO:0048845) | 4.48760875 |
28 | fatty acid homeostasis (GO:0055089) | 4.47890741 |
29 | lung vasculature development (GO:0060426) | 4.45148183 |
30 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.44456812 |
31 | ovulation from ovarian follicle (GO:0001542) | 4.40454621 |
32 | response to dietary excess (GO:0002021) | 4.37713375 |
33 | regulation of cholesterol storage (GO:0010885) | 4.30918927 |
34 | polyol transport (GO:0015791) | 4.25111375 |
35 | chemical homeostasis within a tissue (GO:0048875) | 4.23458391 |
36 | lipid storage (GO:0019915) | 4.18168488 |
37 | plasma lipoprotein particle clearance (GO:0034381) | 4.15724404 |
38 | positive regulation of vascular permeability (GO:0043117) | 4.14914403 |
39 | regulation of glomerular filtration (GO:0003093) | 4.14069968 |
40 | wound healing, spreading of epidermal cells (GO:0035313) | 4.07880208 |
41 | regulation of axon extension involved in axon guidance (GO:0048841) | 4.07748721 |
42 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.05297123 |
43 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 4.01434237 |
44 | cell migration involved in sprouting angiogenesis (GO:0002042) | 4.00395885 |
45 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.95286870 |
46 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.94711363 |
47 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.94711363 |
48 | positive regulation of glomerulus development (GO:0090193) | 3.88756903 |
49 | endothelium development (GO:0003158) | 3.84079240 |
50 | auditory receptor cell stereocilium organization (GO:0060088) | 3.73783901 |
51 | positive regulation of lipid storage (GO:0010884) | 3.70855726 |
52 | ethanol oxidation (GO:0006069) | 3.70652333 |
53 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 3.70608508 |
54 | kidney mesenchyme development (GO:0072074) | 3.70154172 |
55 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.69579575 |
56 | cell differentiation involved in kidney development (GO:0061005) | 3.66272650 |
57 | cellular response to epinephrine stimulus (GO:0071872) | 3.63964030 |
58 | regulation of lipoprotein metabolic process (GO:0050746) | 3.60367088 |
59 | triglyceride metabolic process (GO:0006641) | 3.60070300 |
60 | negative regulation of granulocyte differentiation (GO:0030853) | 3.59630372 |
61 | dopaminergic neuron differentiation (GO:0071542) | 3.58409988 |
62 | regulation of extracellular matrix disassembly (GO:0010715) | 3.56300125 |
63 | triglyceride biosynthetic process (GO:0019432) | 3.55502867 |
64 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.52308231 |
65 | negative regulation of protein autophosphorylation (GO:0031953) | 3.51158749 |
66 | patterning of blood vessels (GO:0001569) | 3.50893625 |
67 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 3.49816144 |
68 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.49315063 |
69 | cGMP-mediated signaling (GO:0019934) | 3.47228542 |
70 | stress fiber assembly (GO:0043149) | 3.46624725 |
71 | renal system process involved in regulation of blood volume (GO:0001977) | 3.45411684 |
72 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 3.41876191 |
73 | neutral lipid biosynthetic process (GO:0046460) | 3.38139507 |
74 | acylglycerol biosynthetic process (GO:0046463) | 3.38139507 |
75 | acylglycerol metabolic process (GO:0006639) | 3.37326383 |
76 | diaphragm development (GO:0060539) | 3.36641607 |
77 | positive regulation of cholesterol efflux (GO:0010875) | 3.36359334 |
78 | positive regulation of protein kinase C signaling (GO:0090037) | 3.36244076 |
79 | protein heterotrimerization (GO:0070208) | 3.35346213 |
80 | positive regulation of histone deacetylation (GO:0031065) | 3.35056064 |
81 | lipid particle organization (GO:0034389) | 3.34823765 |
82 | myoblast fusion (GO:0007520) | 3.33545891 |
83 | neutral lipid metabolic process (GO:0006638) | 3.32243477 |
84 | regulation of gonadotropin secretion (GO:0032276) | 3.32108344 |
85 | white fat cell differentiation (GO:0050872) | 3.31385560 |
86 | regulation of alkaline phosphatase activity (GO:0010692) | 3.31041087 |
87 | fatty acid transmembrane transport (GO:1902001) | 3.30721863 |
88 | positive regulation of focal adhesion assembly (GO:0051894) | 3.28772822 |
89 | positive regulation of cell junction assembly (GO:1901890) | 3.28772822 |
90 | sprouting angiogenesis (GO:0002040) | 3.28336860 |
91 | branching involved in salivary gland morphogenesis (GO:0060445) | 3.28065725 |
92 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 3.27870475 |
93 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.26492549 |
94 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.25990195 |
95 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.25410556 |
96 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.24424529 |
97 | regulation of Rac protein signal transduction (GO:0035020) | 3.23036822 |
98 | negative regulation of amino acid transport (GO:0051956) | 3.19434562 |
99 | regulation of vascular permeability (GO:0043114) | 3.19164970 |
100 | brown fat cell differentiation (GO:0050873) | 3.18718124 |
101 | positive regulation of adherens junction organization (GO:1903393) | 3.16827129 |
102 | oxaloacetate metabolic process (GO:0006107) | 3.16420180 |
103 | response to phenylpropanoid (GO:0080184) | 3.12608684 |
104 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.11369614 |
105 | excretion (GO:0007588) | 3.10573120 |
106 | protein localization to endosome (GO:0036010) | 3.09370760 |
107 | acylglycerol homeostasis (GO:0055090) | 3.08809243 |
108 | triglyceride homeostasis (GO:0070328) | 3.08809243 |
109 | epithelial cell-cell adhesion (GO:0090136) | 3.07716953 |
110 | negative regulation of macrophage differentiation (GO:0045650) | 3.07530483 |
111 | positive regulation of glucose import (GO:0046326) | 3.06503070 |
112 | lipoprotein transport (GO:0042953) | 3.06415071 |
113 | angiogenesis involved in wound healing (GO:0060055) | 3.04076952 |
114 | metanephric mesenchyme development (GO:0072075) | 3.03882291 |
115 | skeletal muscle organ development (GO:0060538) | 3.03838075 |
116 | lymph vessel development (GO:0001945) | 3.02820967 |
117 | negative regulation of platelet activation (GO:0010544) | 3.02575871 |
118 | response to epinephrine (GO:0071871) | 3.01567848 |
119 | glomerular visceral epithelial cell development (GO:0072015) | 23.5952299 |
120 | glomerular epithelial cell development (GO:0072310) | 20.9554591 |
121 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.99799928 |
122 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.99716561 |
123 | glycerol metabolic process (GO:0006071) | 2.99520860 |
124 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.99204413 |
125 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.98500420 |
126 | endocrine hormone secretion (GO:0060986) | 2.97889137 |
127 | biotin metabolic process (GO:0006768) | 2.96067399 |
128 | barbed-end actin filament capping (GO:0051016) | 2.95984203 |
129 | blood vessel endothelial cell migration (GO:0043534) | 2.94441252 |
130 | regulation of corticosteroid hormone secretion (GO:2000846) | 2.94352108 |
131 | glomerular filtration (GO:0003094) | 2.93917535 |
132 | regulation of triglyceride catabolic process (GO:0010896) | 2.93373708 |
133 | positive regulation of glycolytic process (GO:0045821) | 2.92242102 |
134 | regulation of cell adhesion mediated by integrin (GO:0033628) | 2.90608413 |
135 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.90448513 |
136 | positive regulation of vasculogenesis (GO:2001214) | 2.90444899 |
137 | negative regulation of gluconeogenesis (GO:0045721) | 2.90007609 |
138 | positive regulation of sterol transport (GO:0032373) | 2.88798754 |
139 | positive regulation of cholesterol transport (GO:0032376) | 2.88798754 |
140 | T-helper 1 type immune response (GO:0042088) | 2.86997828 |
141 | cardiac muscle cell proliferation (GO:0060038) | 2.85182166 |
142 | metanephric epithelium development (GO:0072207) | 2.83521404 |
143 | ethanol metabolic process (GO:0006067) | 2.82500522 |
144 | apoptotic cell clearance (GO:0043277) | 2.81454018 |
145 | endothelial cell morphogenesis (GO:0001886) | 2.79539096 |
146 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.77550581 |
147 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.77227836 |
148 | ureteric bud development (GO:0001657) | 2.74995979 |
149 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.74504062 |
150 | regulation of receptor binding (GO:1900120) | 2.73595280 |
151 | protein localization to cell surface (GO:0034394) | 2.73528475 |
152 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.73274227 |
153 | wound healing, spreading of cells (GO:0044319) | 2.70506007 |
154 | tricarboxylic acid metabolic process (GO:0072350) | 2.70175718 |
155 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 2.69888708 |
156 | positive regulation of glucose transport (GO:0010828) | 2.69774787 |
157 | syncytium formation (GO:0006949) | 2.69733846 |
158 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.69435649 |
159 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 2.69216343 |
160 | negative regulation of bone resorption (GO:0045779) | 2.68371166 |
161 | primary alcohol metabolic process (GO:0034308) | 2.66637670 |
162 | regulation of platelet aggregation (GO:0090330) | 2.65721858 |
163 | negative regulation of metanephros development (GO:0072217) | 2.65466607 |
164 | positive regulation of steroid hormone secretion (GO:2000833) | 2.64398427 |
165 | mesonephric tubule development (GO:0072164) | 2.63902319 |
166 | negative regulation of vascular permeability (GO:0043116) | 2.63637065 |
167 | mesonephric epithelium development (GO:0072163) | 2.62265517 |
168 | alditol metabolic process (GO:0019400) | 2.62199598 |
169 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.61925520 |
170 | basement membrane organization (GO:0071711) | 2.61166627 |
171 | morphogenesis of an epithelial sheet (GO:0002011) | 2.60880036 |
172 | positive regulation of urine volume (GO:0035810) | 2.59100802 |
173 | positive regulation of axon extension (GO:0045773) | 2.58698924 |
174 | regulation of excretion (GO:0044062) | 2.57964358 |
175 | regulation of sterol transport (GO:0032371) | 2.57621898 |
176 | regulation of cholesterol transport (GO:0032374) | 2.57621898 |
177 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.57325193 |
178 | negative regulation of organic acid transport (GO:0032891) | 2.57039732 |
179 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.56874085 |
180 | endothelial cell migration (GO:0043542) | 2.56485551 |
181 | positive regulation of lipid catabolic process (GO:0050996) | 2.55916901 |
182 | mesodermal cell differentiation (GO:0048333) | 2.52154771 |
183 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.51157803 |
184 | regulation of ruffle assembly (GO:1900027) | 2.51076418 |
185 | positive regulation of actin filament bundle assembly (GO:0032233) | 2.46806115 |
186 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.45463351 |
187 | positive regulation of mesonephros development (GO:0061213) | 2.43924379 |
188 | blood vessel remodeling (GO:0001974) | 2.42991722 |
189 | embryonic heart tube development (GO:0035050) | 2.41883368 |
190 | glomerular basement membrane development (GO:0032836) | 18.2200440 |
191 | glomerulus development (GO:0032835) | 11.6492347 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.81686041 |
2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.69534107 |
3 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.26544909 |
4 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.16865900 |
5 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.11856993 |
6 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.86912447 |
7 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.83738660 |
8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.76972381 |
9 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.58191611 |
10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.58063165 |
11 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 2.42636836 |
12 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.34105872 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.24639935 |
14 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 2.23712369 |
15 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.22115291 |
16 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.14938406 |
17 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.13789194 |
18 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.12063974 |
19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.89536973 |
20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.87534205 |
21 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81684395 |
22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.76638739 |
23 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.74064796 |
24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.74048245 |
25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.72411390 |
26 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.71521387 |
27 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.71521387 |
28 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.71425872 |
29 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.69429313 |
30 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.65530820 |
31 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.65519605 |
32 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.64677060 |
33 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.62863918 |
34 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.62295399 |
35 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62135239 |
36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60227803 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.60103640 |
38 | KDM2B_26808549_Chip-Seq_K562_Human | 1.58267484 |
39 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56002756 |
40 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.51606501 |
41 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.50222961 |
42 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.50134632 |
43 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.49585021 |
44 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48028589 |
45 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.47970577 |
46 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.46941976 |
47 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.46801714 |
48 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.45907299 |
49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.44369867 |
50 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.43783333 |
51 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42538921 |
52 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40423862 |
53 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40279685 |
54 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.37667895 |
55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.37091705 |
56 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36819804 |
57 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.34298785 |
58 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.34142433 |
59 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32473968 |
60 | RXR_22108803_ChIP-Seq_LS180_Human | 1.30420370 |
61 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29778927 |
62 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.29393613 |
63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.28904597 |
64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27595648 |
65 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25532710 |
66 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.25098239 |
67 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23226923 |
68 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.21026697 |
69 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.21026697 |
70 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20314665 |
71 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.19114893 |
72 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.18172643 |
73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.17700537 |
74 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.17306134 |
75 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.16354449 |
76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15194030 |
77 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14307760 |
78 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.11213105 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.09642580 |
80 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.09443191 |
81 | GATA1_22025678_ChIP-Seq_K562_Human | 1.09065044 |
82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.08719932 |
83 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.07724338 |
84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06194018 |
85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05195370 |
86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.04380208 |
87 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04349506 |
88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.04291324 |
89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03595365 |
90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03001648 |
91 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02505274 |
92 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.01691644 |
93 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.01637949 |
94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.00861191 |
95 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.00327235 |
96 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00123285 |
97 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99833437 |
98 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.98639503 |
99 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98341984 |
100 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.97953717 |
101 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97236101 |
102 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97112863 |
103 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.96681672 |
104 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.96569601 |
105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96315992 |
106 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96104033 |
107 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.95497112 |
108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95401909 |
109 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94916866 |
110 | GATA1_19941826_ChIP-Seq_K562_Human | 0.94027965 |
111 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.93526915 |
112 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93028888 |
113 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.93023496 |
114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.92597323 |
115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92417465 |
116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91814780 |
117 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91655821 |
118 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.91639110 |
119 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.91579099 |
120 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.91574675 |
121 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.91424472 |
122 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91393701 |
123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90353605 |
124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89520905 |
125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89262194 |
126 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88875757 |
127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88548143 |
128 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87602129 |
129 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87153407 |
130 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.86832274 |
131 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.86433070 |
132 | P68_20966046_ChIP-Seq_HELA_Human | 0.85984844 |
133 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.85540331 |
134 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.83098552 |
135 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.82844478 |
136 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.82430963 |
137 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82304823 |
138 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.80667909 |
139 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.80667909 |
140 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.80667909 |
141 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.79706563 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005623_abnormal_meninges_morphology | 5.91135401 |
2 | MP0010368_abnormal_lymphatic_system | 5.24862973 |
3 | MP0004272_abnormal_basement_membrane | 5.16370516 |
4 | MP0004084_abnormal_cardiac_muscle | 4.98250298 |
5 | MP0001879_abnormal_lymphatic_vessel | 4.52764339 |
6 | MP0005167_abnormal_blood-brain_barrier | 3.62228189 |
7 | MP0002971_abnormal_brown_adipose | 3.55581110 |
8 | MP0004036_abnormal_muscle_relaxation | 3.20144926 |
9 | MP0001661_extended_life_span | 2.82560811 |
10 | MP0010329_abnormal_lipoprotein_level | 2.72763647 |
11 | MP0009115_abnormal_fat_cell | 2.69909464 |
12 | MP0000537_abnormal_urethra_morphology | 2.62665357 |
13 | MP0000751_myopathy | 2.57102592 |
14 | MP0000230_abnormal_systemic_arterial | 2.41942091 |
15 | MP0002136_abnormal_kidney_physiology | 2.41555763 |
16 | MP0009643_abnormal_urine_homeostasis | 2.36824344 |
17 | MP0005275_abnormal_skin_tensile | 2.31885279 |
18 | MP0010030_abnormal_orbit_morphology | 2.26200066 |
19 | MP0002135_abnormal_kidney_morphology | 2.23840654 |
20 | MP0005332_abnormal_amino_acid | 2.17551661 |
21 | MP0003959_abnormal_lean_body | 2.13089817 |
22 | MP0002876_abnormal_thyroid_physiology | 2.09147982 |
23 | MP0008438_abnormal_cutaneous_collagen | 2.08461950 |
24 | MP0003942_abnormal_urinary_system | 2.07193708 |
25 | MP0000534_abnormal_ureter_morphology | 2.06473501 |
26 | MP0009384_cardiac_valve_regurgitation | 1.97408685 |
27 | MP0002970_abnormal_white_adipose | 1.96157154 |
28 | MP0005334_abnormal_fat_pad | 1.92714880 |
29 | MP0003724_increased_susceptibility_to | 1.87224847 |
30 | MP0005535_abnormal_body_temperature | 1.83605185 |
31 | MP0002295_abnormal_pulmonary_circulatio | 1.82135100 |
32 | MP0000013_abnormal_adipose_tissue | 1.76960649 |
33 | MP0003868_abnormal_feces_composition | 1.76550580 |
34 | MP0005503_abnormal_tendon_morphology | 1.71317464 |
35 | MP0008775_abnormal_heart_ventricle | 1.70302068 |
36 | MP0005409_darkened_coat_color | 1.69958555 |
37 | MP0001756_abnormal_urination | 1.67247976 |
38 | MP0002108_abnormal_muscle_morphology | 1.65205586 |
39 | MP0003566_abnormal_cell_adhesion | 1.64179144 |
40 | MP0008961_abnormal_basal_metabolism | 1.61629396 |
41 | MP0002118_abnormal_lipid_homeostasis | 1.60959342 |
42 | MP0003011_delayed_dark_adaptation | 1.59972895 |
43 | MP0006138_congestive_heart_failure | 1.56597822 |
44 | MP0005448_abnormal_energy_balance | 1.54590159 |
45 | MP0004185_abnormal_adipocyte_glucose | 1.51862804 |
46 | MP0002128_abnormal_blood_circulation | 1.48092423 |
47 | MP0003283_abnormal_digestive_organ | 1.47923849 |
48 | MP0000678_abnormal_parathyroid_gland | 1.45762223 |
49 | MP0005197_abnormal_uvea_morphology | 1.41244644 |
50 | MP0003091_abnormal_cell_migration | 1.40812445 |
51 | MP0005360_urolithiasis | 1.38185222 |
52 | MP0000767_abnormal_smooth_muscle | 1.34938666 |
53 | MP0004215_abnormal_myocardial_fiber | 1.30487191 |
54 | MP0001614_abnormal_blood_vessel | 1.29518364 |
55 | MP0003941_abnormal_skin_development | 1.29366487 |
56 | MP0001915_intracranial_hemorrhage | 1.27705888 |
57 | MP0001544_abnormal_cardiovascular_syste | 1.26222563 |
58 | MP0005385_cardiovascular_system_phenoty | 1.26222563 |
59 | MP0005187_abnormal_penis_morphology | 1.25867336 |
60 | MP0003950_abnormal_plasma_membrane | 1.25847233 |
61 | MP0002933_joint_inflammation | 1.25357998 |
62 | MP0000747_muscle_weakness | 1.23986086 |
63 | MP0002638_abnormal_pupillary_reflex | 1.19635571 |
64 | MP0003828_pulmonary_edema | 1.16797846 |
65 | MP0001958_emphysema | 1.16244508 |
66 | MP0000003_abnormal_adipose_tissue | 1.15707585 |
67 | MP0000759_abnormal_skeletal_muscle | 1.14606957 |
68 | MP0005452_abnormal_adipose_tissue | 1.13621104 |
69 | MP0003279_aneurysm | 1.12910388 |
70 | MP0001784_abnormal_fluid_regulation | 1.12818036 |
71 | MP0002972_abnormal_cardiac_muscle | 1.12053303 |
72 | MP0003186_abnormal_redox_activity | 1.09161785 |
73 | MP0010307_abnormal_tumor_latency | 1.08562254 |
74 | MP0003705_abnormal_hypodermis_morpholog | 1.08490858 |
75 | MP0004233_abnormal_muscle_weight | 1.06269083 |
76 | MP0003300_gastrointestinal_ulcer | 1.05879668 |
77 | MP0002909_abnormal_adrenal_gland | 1.05329933 |
78 | MP0000579_abnormal_nail_morphology | 1.04714799 |
79 | MP0005365_abnormal_bile_salt | 1.04672722 |
80 | MP0003191_abnormal_cellular_cholesterol | 1.03184439 |
81 | MP0005165_increased_susceptibility_to | 1.02789855 |
82 | MP0002925_abnormal_cardiovascular_devel | 1.01314301 |
83 | MP0000749_muscle_degeneration | 1.01088952 |
84 | MP0003303_peritoneal_inflammation | 1.00841890 |
85 | MP0002078_abnormal_glucose_homeostasis | 0.98659675 |
86 | MP0001501_abnormal_sleep_pattern | 0.98631193 |
87 | MP0005620_abnormal_muscle_contractility | 0.95511045 |
88 | MP0003948_abnormal_gas_homeostasis | 0.95152767 |
89 | MP0005595_abnormal_vascular_smooth | 0.94714245 |
90 | MP0003115_abnormal_respiratory_system | 0.93646075 |
91 | MP0005375_adipose_tissue_phenotype | 0.90400315 |
92 | MP0010630_abnormal_cardiac_muscle | 0.90157475 |
93 | MP0004130_abnormal_muscle_cell | 0.89937658 |
94 | MP0002138_abnormal_hepatobiliary_system | 0.89815122 |
95 | MP0000343_altered_response_to | 0.89523282 |
96 | MP0004484_altered_response_of | 0.87980737 |
97 | MP0002090_abnormal_vision | 0.86201836 |
98 | MP0005670_abnormal_white_adipose | 0.86069314 |
99 | MP0005379_endocrine/exocrine_gland_phen | 0.85748239 |
100 | MP0005647_abnormal_sex_gland | 0.84726646 |
101 | MP0000163_abnormal_cartilage_morphology | 0.81542393 |
102 | MP0005666_abnormal_adipose_tissue | 0.81087507 |
103 | MP0004859_abnormal_synaptic_plasticity | 0.80827432 |
104 | MP0002998_abnormal_bone_remodeling | 0.80766843 |
105 | MP0005164_abnormal_response_to | 0.80393924 |
106 | MP0004782_abnormal_surfactant_physiolog | 0.79276757 |
107 | MP0005193_abnormal_anterior_eye | 0.78781630 |
108 | MP0003879_abnormal_hair_cell | 0.78345823 |
109 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77240811 |
110 | MP0003937_abnormal_limbs/digits/tail_de | 0.76871494 |
111 | MP0005369_muscle_phenotype | 0.76407145 |
112 | MP0002796_impaired_skin_barrier | 0.76210538 |
113 | MP0000858_altered_metastatic_potential | 0.75525965 |
114 | MP0000609_abnormal_liver_physiology | 0.75525842 |
115 | MP0003935_abnormal_craniofacial_develop | 0.74621818 |
116 | MP0003075_altered_response_to | 0.72590763 |
117 | MP0001764_abnormal_homeostasis | 0.70810203 |
118 | MP0004858_abnormal_nervous_system | 0.67203582 |
119 | MP0001346_abnormal_lacrimal_gland | 0.65832303 |
120 | MP0004087_abnormal_muscle_fiber | 0.63946601 |
121 | MP0002269_muscular_atrophy | 0.62277421 |
122 | MP0003252_abnormal_bile_duct | 0.61972799 |
123 | MP0001175_abnormal_lung_morphology | 0.61907043 |
124 | MP0002932_abnormal_joint_morphology | 0.61900371 |
125 | MP0010386_abnormal_urinary_bladder | 0.61289376 |
126 | MP0000516_abnormal_urinary_system | 0.61168853 |
127 | MP0005367_renal/urinary_system_phenotyp | 0.61168853 |
128 | MP0001851_eye_inflammation | 0.60865784 |
129 | MP0006036_abnormal_mitochondrial_physio | 0.60259155 |
130 | MP0002896_abnormal_bone_mineralization | 0.60150301 |
131 | MP0002115_abnormal_skeleton_extremities | 0.59975594 |
132 | MP0005508_abnormal_skeleton_morphology | 0.59644583 |
133 | MP0001324_abnormal_eye_pigmentation | 0.59047027 |
134 | MP0003690_abnormal_glial_cell | 0.58941079 |
135 | MP0000266_abnormal_heart_morphology | 0.58899554 |
136 | MP0001765_abnormal_ion_homeostasis | 0.58776094 |
137 | MP0005058_abnormal_lysosome_morphology | 0.56993363 |
138 | MP0001727_abnormal_embryo_implantation | 0.56637327 |
139 | MP0001286_abnormal_eye_development | 0.56389331 |
140 | MP0005166_decreased_susceptibility_to | 0.56360271 |
141 | MP0005451_abnormal_body_composition | 0.56222010 |
142 | MP0005330_cardiomyopathy | 0.56042146 |
143 | MP0003385_abnormal_body_wall | 0.55874470 |
144 | MP0002106_abnormal_muscle_physiology | 0.55381291 |
145 | MP0000249_abnormal_blood_vessel | 0.55318734 |
146 | MP0002133_abnormal_respiratory_system | 0.55300481 |
147 | MP0005388_respiratory_system_phenotype | 0.55300481 |
148 | MP0002113_abnormal_skeleton_development | 0.55180808 |
149 | MP0009780_abnormal_chondrocyte_physiolo | 0.54984756 |
150 | MP0003953_abnormal_hormone_level | 0.54944120 |
151 | MP0006276_abnormal_autonomic_nervous | 0.54563215 |
152 | MP0000477_abnormal_intestine_morphology | 0.53335925 |
153 | MP0001881_abnormal_mammary_gland | 0.52848932 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Hypoalbuminemia (HP:0003073) | 9.50155264 |
2 | Abnormal albumin level (HP:0012116) | 9.50155264 |
3 | Glomerulosclerosis (HP:0000096) | 8.97244841 |
4 | Nephritis (HP:0000123) | 6.71987670 |
5 | Glomerulonephritis (HP:0000099) | 6.41531828 |
6 | Stage 5 chronic kidney disease (HP:0003774) | 6.19122614 |
7 | Oligomenorrhea (HP:0000876) | 6.01105995 |
8 | Tubular atrophy (HP:0000092) | 5.52946467 |
9 | Acanthosis nigricans (HP:0000956) | 5.35170389 |
10 | Hypertriglyceridemia (HP:0002155) | 5.20844951 |
11 | Hypoproteinemia (HP:0003075) | 5.10617828 |
12 | Nephrotic syndrome (HP:0000100) | 4.95207019 |
13 | Neonatal respiratory distress (HP:0002643) | 4.91131331 |
14 | Increased variability in muscle fiber diameter (HP:0003557) | 4.58374734 |
15 | Protrusio acetabuli (HP:0003179) | 4.55088330 |
16 | Muscle fiber splitting (HP:0003555) | 4.42695229 |
17 | Metaphyseal dysplasia (HP:0100255) | 4.40153829 |
18 | Rapidly progressive (HP:0003678) | 4.29911094 |
19 | Hemorrhage of the eye (HP:0011885) | 4.12364596 |
20 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.05443162 |
21 | Difficulty running (HP:0009046) | 4.00404192 |
22 | Lymphangioma (HP:0100764) | 3.95549205 |
23 | Proteinuria (HP:0000093) | 3.85779506 |
24 | Increased connective tissue (HP:0009025) | 3.83029254 |
25 | Corneal erosion (HP:0200020) | 3.73513305 |
26 | Complement deficiency (HP:0004431) | 3.56668380 |
27 | Insulin resistance (HP:0000855) | 3.42835552 |
28 | Myocardial infarction (HP:0001658) | 3.41902487 |
29 | Nonprogressive disorder (HP:0003680) | 3.40599374 |
30 | Spinal rigidity (HP:0003306) | 3.29288513 |
31 | Hematuria (HP:0000790) | 3.25412537 |
32 | Skin nodule (HP:0200036) | 3.25096410 |
33 | Pigmentary retinal degeneration (HP:0001146) | 3.22965775 |
34 | Deep venous thrombosis (HP:0002625) | 3.15490408 |
35 | Hyperlipoproteinemia (HP:0010980) | 3.15252195 |
36 | Tubulointerstitial fibrosis (HP:0005576) | 3.10521828 |
37 | Increased circulating renin level (HP:0000848) | 3.09261366 |
38 | Abnormality of complement system (HP:0005339) | 3.08344121 |
39 | Metaphyseal cupping (HP:0003021) | 3.06924168 |
40 | Xanthomatosis (HP:0000991) | 2.96445006 |
41 | Abnormal tarsal ossification (HP:0008369) | 2.90603555 |
42 | Systemic lupus erythematosus (HP:0002725) | 2.90107961 |
43 | Visceral angiomatosis (HP:0100761) | 2.88432121 |
44 | Epidermoid cyst (HP:0200040) | 2.85146343 |
45 | Polar cataract (HP:0010696) | 2.83414976 |
46 | Hypercholesterolemia (HP:0003124) | 2.81189590 |
47 | Hypokalemic alkalosis (HP:0001949) | 2.79517251 |
48 | Growth hormone excess (HP:0000845) | 2.78054900 |
49 | Abnormal eating behavior (HP:0100738) | 2.74807165 |
50 | Back pain (HP:0003418) | 2.69330427 |
51 | Hemangiomatosis (HP:0007461) | 2.66116858 |
52 | Hyporeflexia of lower limbs (HP:0002600) | 2.64853413 |
53 | Asymmetric septal hypertrophy (HP:0001670) | 2.62760406 |
54 | Hematochezia (HP:0002573) | 2.62625118 |
55 | Persistence of primary teeth (HP:0006335) | 2.62337353 |
56 | Hypercortisolism (HP:0001578) | 2.61553339 |
57 | Axonal loss (HP:0003447) | 2.60236170 |
58 | Exercise-induced myalgia (HP:0003738) | 2.58471870 |
59 | Joint hemorrhage (HP:0005261) | 2.56847636 |
60 | Neck muscle weakness (HP:0000467) | 2.54620770 |
61 | Ridged nail (HP:0001807) | 2.52683228 |
62 | Vertebral compression fractures (HP:0002953) | 2.51590394 |
63 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.50118932 |
64 | Bone cyst (HP:0012062) | 2.48612202 |
65 | Subcapsular cataract (HP:0000523) | 2.46679402 |
66 | Retinal atrophy (HP:0001105) | 2.46621562 |
67 | Type 1 muscle fiber predominance (HP:0003803) | 2.45885657 |
68 | Ectopia lentis (HP:0001083) | 2.45750281 |
69 | Amyloidosis (HP:0011034) | 2.44623538 |
70 | Pterygium (HP:0001059) | 2.42997963 |
71 | Aplasia of the musculature (HP:0100854) | 2.41631384 |
72 | Polycythemia (HP:0001901) | 2.40144640 |
73 | Coronal craniosynostosis (HP:0004440) | 2.39763160 |
74 | Autoimmune thrombocytopenia (HP:0001973) | 2.35403952 |
75 | Myotonia (HP:0002486) | 2.34814116 |
76 | Frequent falls (HP:0002359) | 2.32180709 |
77 | Down-sloping shoulders (HP:0200021) | 2.31820232 |
78 | Vascular tortuosity (HP:0004948) | 2.30432767 |
79 | Colitis (HP:0002583) | 2.28729201 |
80 | Interstitial pulmonary disease (HP:0006530) | 2.27002030 |
81 | Hypomagnesemia (HP:0002917) | 2.24616116 |
82 | Ileus (HP:0002595) | 2.22939119 |
83 | Atrioventricular block (HP:0001678) | 2.21049651 |
84 | Lipoatrophy (HP:0100578) | 2.20843838 |
85 | Striae distensae (HP:0001065) | 2.20097930 |
86 | Hip contracture (HP:0003273) | 2.18726235 |
87 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.16864731 |
88 | Aortic aneurysm (HP:0004942) | 2.16720635 |
89 | Concave nail (HP:0001598) | 2.16273907 |
90 | Venous insufficiency (HP:0005293) | 2.15699385 |
91 | Abnormality of the pulmonary veins (HP:0011718) | 2.15572074 |
92 | Prominent supraorbital ridges (HP:0000336) | 2.11730689 |
93 | Ankle contracture (HP:0006466) | 2.11691393 |
94 | Obstructive sleep apnea (HP:0002870) | 2.11028328 |
95 | Facial shape deformation (HP:0011334) | 2.10583568 |
96 | Potter facies (HP:0002009) | 2.10583568 |
97 | Hypophosphatemia (HP:0002148) | 2.09597615 |
98 | Abnormality of the fingertips (HP:0001211) | 2.08287202 |
99 | Easy fatigability (HP:0003388) | 2.07904948 |
100 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.06495088 |
101 | Arterial tortuosity (HP:0005116) | 2.05769538 |
102 | Anomalous pulmonary venous return (HP:0010772) | 2.05707568 |
103 | Bulbar palsy (HP:0001283) | 2.05355682 |
104 | Abnormal foot bone ossification (HP:0010675) | 2.04603015 |
105 | Wormian bones (HP:0002645) | 2.01848134 |
106 | Delayed epiphyseal ossification (HP:0002663) | 2.00972453 |
107 | Mesangial abnormality (HP:0001966) | 13.1954232 |
108 | Focal segmental glomerulosclerosis (HP:0000097) | 11.4960877 |
109 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.99640169 |
110 | Hyperactive renin-angiotensin system (HP:0000841) | 1.97442906 |
111 | Hypoparathyroidism (HP:0000829) | 1.97139213 |
112 | Cervical subluxation (HP:0003308) | 1.96700811 |
113 | Gowers sign (HP:0003391) | 1.96577341 |
114 | Nausea (HP:0002018) | 1.96406140 |
115 | Foot dorsiflexor weakness (HP:0009027) | 1.96066170 |
116 | Accelerated skeletal maturation (HP:0005616) | 1.92891869 |
117 | Germ cell neoplasia (HP:0100728) | 1.90186105 |
118 | Muscle stiffness (HP:0003552) | 1.89928128 |
119 | Hypoalphalipoproteinemia (HP:0003233) | 1.89342583 |
120 | Abnormal atrioventricular conduction (HP:0005150) | 1.89224108 |
121 | Abnormality of the periventricular white matter (HP:0002518) | 1.88927051 |
122 | Shawl scrotum (HP:0000049) | 1.87866667 |
123 | Rhabdomyolysis (HP:0003201) | 1.87077038 |
124 | Cavernous hemangioma (HP:0001048) | 1.85655017 |
125 | Mitral valve prolapse (HP:0001634) | 1.85072854 |
126 | Nonimmune hydrops fetalis (HP:0001790) | 1.83551364 |
127 | Premature rupture of membranes (HP:0001788) | 1.83292425 |
128 | Polygenic inheritance (HP:0010982) | 1.81940900 |
129 | Broad metatarsal (HP:0001783) | 1.81723168 |
130 | Venous abnormality (HP:0002624) | 1.81316560 |
131 | Exostoses (HP:0100777) | 1.80535171 |
132 | Abnormality of magnesium homeostasis (HP:0004921) | 1.80153222 |
133 | Abnormality of the foot musculature (HP:0001436) | 1.78585317 |
134 | Choanal stenosis (HP:0000452) | 1.77292564 |
135 | Chondrocalcinosis (HP:0000934) | 1.76006761 |
136 | Heart block (HP:0012722) | 1.75941142 |
137 | Distal lower limb amyotrophy (HP:0008944) | 1.75025375 |
138 | Wide cranial sutures (HP:0010537) | 1.72349321 |
139 | Stroke (HP:0001297) | 1.70683785 |
140 | Abnormality of renin-angiotensin system (HP:0000847) | 1.69627282 |
141 | Coxa vara (HP:0002812) | 1.69626967 |
142 | Cerebral aneurysm (HP:0004944) | 1.69331514 |
143 | Nephrocalcinosis (HP:0000121) | 1.68910354 |
144 | Hypoplastic left heart (HP:0004383) | 1.68501664 |
145 | Aneurysm (HP:0002617) | 1.68247763 |
146 | Bronchomalacia (HP:0002780) | 1.67171007 |
147 | Abnormality of proline metabolism (HP:0010907) | 1.66502831 |
148 | Hydroxyprolinuria (HP:0003080) | 1.66502831 |
149 | Prolonged bleeding time (HP:0003010) | 1.65712918 |
150 | Aqueductal stenosis (HP:0002410) | 1.64857520 |
151 | Distal lower limb muscle weakness (HP:0009053) | 1.64535588 |
152 | Large hands (HP:0001176) | 1.64508994 |
153 | Abnormality of chloride homeostasis (HP:0011422) | 1.63596975 |
154 | Tubulointerstitial abnormality (HP:0001969) | 1.62856569 |
155 | Abdominal distention (HP:0003270) | 1.62062054 |
156 | Spontaneous hematomas (HP:0007420) | 1.61948618 |
157 | Abnormality of Sharpey fibers (HP:0100685) | 1.61460027 |
158 | Renal duplication (HP:0000075) | 1.60946084 |
159 | Cerebral hemorrhage (HP:0001342) | 1.60181939 |
160 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.59909869 |
161 | Tetany (HP:0001281) | 1.59371561 |
162 | Rectal prolapse (HP:0002035) | 1.59280080 |
163 | Knee flexion contracture (HP:0006380) | 1.58782707 |
164 | Recurrent corneal erosions (HP:0000495) | 1.57744294 |
165 | Hypoplasia of the iris (HP:0007676) | 1.55018530 |
166 | Abnormality of the peritoneum (HP:0002585) | 1.54787365 |
167 | Limited hip movement (HP:0008800) | 1.53375681 |
168 | Advanced eruption of teeth (HP:0006288) | 1.52487880 |
169 | Absent phalangeal crease (HP:0006109) | 1.52168433 |
170 | Turricephaly (HP:0000262) | 1.51980598 |
171 | Glomerulopathy (HP:0100820) | 1.50350790 |
172 | Hypercalciuria (HP:0002150) | 1.47564840 |
173 | Testicular neoplasm (HP:0010788) | 1.47031124 |
174 | Abnormality of carpal bone ossification (HP:0006257) | 1.42364755 |
175 | Esophageal varix (HP:0002040) | 1.37184177 |
176 | Abnormality of the nasal mucosa (HP:0000433) | 1.36503768 |
177 | Hypokalemia (HP:0002900) | 1.34103822 |
178 | Sensorimotor neuropathy (HP:0007141) | 1.28704044 |
179 | Exotropia (HP:0000577) | 1.28591194 |
180 | Shallow orbits (HP:0000586) | 1.28004345 |
181 | Increased CSF protein (HP:0002922) | 1.27422943 |
182 | Seborrheic dermatitis (HP:0001051) | 1.27329405 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 5.89064083 |
2 | TIE1 | 5.48228492 |
3 | EPHB2 | 5.11316813 |
4 | OXSR1 | 4.45456963 |
5 | PAK4 | 4.41137951 |
6 | STK39 | 4.16522637 |
7 | MYLK | 3.08235168 |
8 | TGFBR2 | 2.91323703 |
9 | DDR2 | 2.65847154 |
10 | TRIB3 | 2.35688555 |
11 | PRKAA2 | 2.32588158 |
12 | EEF2K | 2.28894113 |
13 | KDR | 2.22452955 |
14 | EPHB1 | 2.19954136 |
15 | TESK1 | 1.78634427 |
16 | CAMK1 | 1.76027733 |
17 | MAP3K6 | 1.73424115 |
18 | FGFR4 | 1.48734639 |
19 | LATS1 | 1.44300816 |
20 | MAPKAPK3 | 1.39057105 |
21 | FER | 1.35835876 |
22 | MAP3K7 | 1.32021121 |
23 | MAPK4 | 1.30260165 |
24 | TGFBR1 | 1.28075921 |
25 | MAPK15 | 1.24149811 |
26 | CDK19 | 1.23174702 |
27 | PDGFRA | 1.22742381 |
28 | ERN1 | 1.20443046 |
29 | GRK5 | 1.16871286 |
30 | CAMK2B | 1.16487606 |
31 | RIPK1 | 1.16304607 |
32 | ROCK1 | 1.12417178 |
33 | PTK6 | 1.12213981 |
34 | LRRK2 | 1.10685453 |
35 | NTRK1 | 1.06479777 |
36 | OBSCN | 1.05804985 |
37 | PTK2B | 1.04747662 |
38 | ICK | 1.02090288 |
39 | FGFR2 | 1.01074972 |
40 | ARAF | 1.00995905 |
41 | MST4 | 0.98562746 |
42 | WNK1 | 0.96847018 |
43 | PRKAA1 | 0.95819702 |
44 | SIK1 | 0.95781767 |
45 | NME1 | 0.94361903 |
46 | PAK2 | 0.92590461 |
47 | GRK1 | 0.91731015 |
48 | PRKCH | 0.91224900 |
49 | PAK3 | 0.90290942 |
50 | PRPF4B | 0.88230931 |
51 | CDC42BPA | 0.87877989 |
52 | TTN | 0.86820684 |
53 | GSK3A | 0.86737091 |
54 | MAPK7 | 0.86123204 |
55 | MAP2K1 | 0.82876680 |
56 | LATS2 | 0.81088340 |
57 | CDK6 | 0.80115887 |
58 | MOS | 0.76304224 |
59 | TSSK6 | 0.73948558 |
60 | PRKD3 | 0.73583403 |
61 | RIPK4 | 0.72789362 |
62 | PDPK1 | 0.65827965 |
63 | DAPK2 | 0.65739910 |
64 | JAK1 | 0.65059140 |
65 | TYRO3 | 0.63343057 |
66 | PRKG2 | 0.63088972 |
67 | PTK2 | 0.62393245 |
68 | DMPK | 0.61224271 |
69 | NLK | 0.57253589 |
70 | PRKG1 | 0.57158296 |
71 | BMX | 0.56921087 |
72 | PRKD1 | 0.56274494 |
73 | STK10 | 0.54315986 |
74 | JAK2 | 0.53684228 |
75 | FGFR3 | 0.53620483 |
76 | NEK9 | 0.52461277 |
77 | PRKCE | 0.51656034 |
78 | CAMK1G | 0.51454990 |
79 | PDK2 | 0.50603021 |
80 | PDGFRB | 0.49710332 |
81 | MAP2K3 | 0.48415793 |
82 | MAPKAPK5 | 0.48398635 |
83 | MAPK9 | 0.48014229 |
84 | RPS6KA2 | 0.47669406 |
85 | PIK3CA | 0.47656413 |
86 | SGK494 | 0.47305754 |
87 | SGK223 | 0.47305754 |
88 | TYK2 | 0.46783140 |
89 | SRC | 0.46716805 |
90 | ABL2 | 0.46492064 |
91 | PHKG1 | 0.46289757 |
92 | PHKG2 | 0.46289757 |
93 | FES | 0.45473375 |
94 | KSR2 | 0.45309493 |
95 | CAMK1D | 0.45071805 |
96 | STK38 | 0.44632644 |
97 | FGFR1 | 0.44526612 |
98 | MAPK3 | 0.44097577 |
99 | MARK2 | 0.43629499 |
100 | ZAP70 | 0.42589835 |
101 | SGK2 | 0.42288164 |
102 | MARK1 | 0.41895730 |
103 | PRKD2 | 0.41412293 |
104 | MAP3K13 | 0.41057926 |
105 | KIT | 0.40838504 |
106 | RPS6KA3 | 0.40835973 |
107 | CSK | 0.39986794 |
108 | PKN1 | 0.39836302 |
109 | MAPK12 | 0.39506435 |
110 | MTOR | 0.39502584 |
111 | PKN2 | 0.39476217 |
112 | CDK15 | 0.37578716 |
113 | MAP3K11 | 0.37035887 |
114 | STK38L | 0.36823480 |
115 | DAPK3 | 0.36407990 |
116 | DYRK1B | 0.35759703 |
117 | IGF1R | 0.35611821 |
118 | FYN | 0.35314556 |
119 | CDK9 | 0.35153294 |
120 | CDK14 | 0.35127381 |
121 | TBK1 | 0.33852150 |
122 | CDK11A | 0.33105468 |
123 | EPHA3 | 0.32832286 |
124 | NEK1 | 0.32671278 |
125 | NTRK3 | 0.32551715 |
126 | CDK18 | 0.32372307 |
127 | PDK1 | 0.31761920 |
128 | MAP3K3 | 0.29976912 |
129 | MAP3K2 | 0.28381252 |
130 | PRKACG | 0.26014998 |
131 | PAK6 | 0.25831351 |
132 | CDK5 | 0.25351524 |
133 | ROCK2 | 0.24981890 |
134 | RET | 0.24601881 |
135 | MAP3K1 | 0.24219589 |
136 | LMTK2 | 0.23708039 |
137 | EGFR | 0.23608818 |
138 | SGK3 | 0.23221692 |
139 | TRPM7 | 0.22172572 |
140 | EPHA2 | 0.21708003 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 4.39804503 |
2 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.93200760 |
3 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 3.19582884 |
4 | Small cell lung cancer_Homo sapiens_hsa05222 | 2.73857205 |
5 | Focal adhesion_Homo sapiens_hsa04510 | 2.71024137 |
6 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 2.70595280 |
7 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.65572406 |
8 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.64289767 |
9 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.59046226 |
10 | Amoebiasis_Homo sapiens_hsa05146 | 2.46994553 |
11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.38540760 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.29865864 |
13 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.26764908 |
14 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.14268114 |
15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.01434691 |
16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01342439 |
17 | * Axon guidance_Homo sapiens_hsa04360 | 1.89329019 |
18 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.87183310 |
19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.83680739 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.70970276 |
21 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.65645935 |
22 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.62348579 |
23 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.59285990 |
24 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.55026817 |
25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54209530 |
26 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.50633406 |
27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.49211499 |
28 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.47974638 |
29 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.45507638 |
30 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.38158085 |
31 | Bladder cancer_Homo sapiens_hsa05219 | 1.33601124 |
32 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.29595421 |
33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.29273943 |
34 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27178140 |
35 | Adherens junction_Homo sapiens_hsa04520 | 1.24071841 |
36 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.22958199 |
37 | Renin secretion_Homo sapiens_hsa04924 | 1.21526351 |
38 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20838363 |
39 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.17755447 |
40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.16368218 |
41 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.15970771 |
42 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15126373 |
43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.14514607 |
44 | Tight junction_Homo sapiens_hsa04530 | 1.11316043 |
45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10058382 |
46 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.07285564 |
47 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.04377154 |
48 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.01945236 |
49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01081543 |
50 | Platelet activation_Homo sapiens_hsa04611 | 1.00469201 |
51 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.98241640 |
52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.98106037 |
53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.97897806 |
54 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.97647349 |
55 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.97043316 |
56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.91231300 |
57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89689080 |
58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.86191848 |
59 | Pathways in cancer_Homo sapiens_hsa05200 | 0.86097240 |
60 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.85743765 |
61 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.84240381 |
62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.84191368 |
63 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81703664 |
64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.81679404 |
65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81252186 |
66 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80886201 |
67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79985188 |
68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78018876 |
69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76746707 |
70 | Prion diseases_Homo sapiens_hsa05020 | 0.74820727 |
71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73523142 |
72 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.72899246 |
73 | Malaria_Homo sapiens_hsa05144 | 0.72382010 |
74 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70926446 |
75 | Bile secretion_Homo sapiens_hsa04976 | 0.69740521 |
76 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.69582658 |
77 | Endocytosis_Homo sapiens_hsa04144 | 0.68449174 |
78 | Lysine degradation_Homo sapiens_hsa00310 | 0.66772867 |
79 | Gap junction_Homo sapiens_hsa04540 | 0.66708079 |
80 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.66529245 |
81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65762686 |
82 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.65214567 |
83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.64437636 |
84 | Insulin resistance_Homo sapiens_hsa04931 | 0.64278756 |
85 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.63367202 |
86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.61422481 |
87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.61209833 |
88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58830652 |
89 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58504813 |
90 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58215240 |
91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.57640760 |
92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.57498839 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.56789320 |
94 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.56129701 |
95 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.55633509 |
96 | Lysosome_Homo sapiens_hsa04142 | 0.55423589 |
97 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55421318 |
98 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53876422 |
99 | Phagosome_Homo sapiens_hsa04145 | 0.51528361 |
100 | Carbon metabolism_Homo sapiens_hsa01200 | 0.51154797 |
101 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50887884 |
102 | Salivary secretion_Homo sapiens_hsa04970 | 0.50522498 |
103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50142060 |
104 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.48962144 |
105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47797415 |
106 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47267635 |
107 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46732068 |
108 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45185778 |
109 | Glioma_Homo sapiens_hsa05214 | 0.45035519 |
110 | Sulfur relay system_Homo sapiens_hsa04122 | 0.43460859 |
111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41392219 |
112 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41365925 |
113 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41352319 |
114 | Prostate cancer_Homo sapiens_hsa05215 | 0.38785875 |
115 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.38707643 |
116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.38613195 |
117 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.38419938 |
118 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.37826589 |
119 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36487207 |
120 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.35838907 |
121 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.35814719 |
122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.35503821 |
123 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35033247 |
124 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34808370 |
125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.34711501 |
126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.34377512 |
127 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.34369575 |
128 | Insulin secretion_Homo sapiens_hsa04911 | 0.32152627 |
129 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31719286 |
130 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30300526 |
131 | Melanogenesis_Homo sapiens_hsa04916 | 0.30250979 |
132 | Long-term potentiation_Homo sapiens_hsa04720 | 0.30001747 |
133 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29603107 |
134 | Cocaine addiction_Homo sapiens_hsa05030 | 0.29349650 |
135 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29215648 |
136 | ABC transporters_Homo sapiens_hsa02010 | 0.28124096 |
137 | Morphine addiction_Homo sapiens_hsa05032 | 0.27877555 |
138 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27385146 |
139 | Salmonella infection_Homo sapiens_hsa05132 | 0.26669523 |
140 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.26550047 |
141 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.25502348 |
142 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.24415144 |
143 | Circadian entrainment_Homo sapiens_hsa04713 | 0.23258506 |
144 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.23242031 |